Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED BALANCE SHEET

v3.23.3
CONDENSED CONSOLIDATED BALANCE SHEET - USD ($)
Sep. 30, 2023
Dec. 31, 2022
CURRENT ASSETS:    
Cash $ 1,484,644 $ 1,799,263
Accounts receivable 2,593 0
Prepaid expenses 460,632 102,416
Total current assets 1,947,869 1,901,679
PROPERTY AND EQUIPMENT, NET 0 0
OTHER ASSETS    
Operating lease - right of use asset 122,110 189,282
Security deposit 32,058 32,058
Total other assets 154,168 221,340
TOTAL ASSETS 2,102,037 2,123,019
Accounts payable 643,812 490,670
Current portion of long-term operating lease 110,398 99,259
Convertible debentures payable 240,000 240,000
Deferred R&D obligations - participation agreements 57,906 525,904
Deferred R&D obligations - participation agreements related parties 19,316 175,427
Short term loans payable, net of discount 1,129,696 0
Accrued interest 149,145 98,286
Accrued liabilities - payroll and directors fees 823,779 398,176
Total Current Liabilities 3,174,052 2,027,722
LONG-TERM LIABILITIES:    
Long-term operating lease, net of current portion 22,027 105,919
Total long-term liabilities 22,027 105,919
TOTAL LIABILITIES 3,196,079 2,133,641
STOCKHOLDERS' EQUITY:    
Common stock, $0.001 par value, 25,000,000 shares authorized; 1,741,610 and 1,569,943 issued and outstanding at September 30, 2023 and December 31, 2022 (a) 1,742 1,570
Additional paid-in capital (a) 120,577,382 115,792,337
Accumulated deficit (121,673,166) (115,804,529)
Total stockholders' equity (1,094,042) (10,622)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 2,102,037 $ 2,123,019